DNA damage response--a double-edged sword in cancer prevention and cancer therapy

Area of Science:

• Genetics
• Molecular Biology
• Cancer Research

Background:

• Genomic stability relies on effective DNA damage repair (DDR) to maintain chromosomal integrity.
• Accumulated unrepaired DNA damage can lead to cell cycle arrest, apoptosis, and genome mutations, contributing to cancer development.
• Germline mutations in DDR genes are linked to a high predisposition to human cancers.

Purpose of the Study:

• To explore the dual role of DNA damage response (DDR) in cancer prevention and therapy.
• To investigate the potential of targeting DDR pathways for cancer treatment.
• To understand how defective DDR in cancer cells can be exploited for therapeutic gain.

Main Methods:

• Review of existing literature on DNA damage repair pathways and their role in cancer.
• Analysis of the paradoxical functions of DDR in tumorigenesis and treatment resistance.
• Conceptual exploration of therapeutic strategies targeting DDR proteins.

Main Results:

• DNA damage response (DDR) acts as a 'double-edged sword' in cancer, protecting against genome instability but also conferring resistance to therapies.
• Defective DDR pathways in cancer cells contribute to high mutability and malignant transformation.
• Targeting specific proteins within DDR pathways presents a viable strategy for cancer therapy.

Conclusions:

• Inhibiting DDR pathways can sensitize cancer cells to clinical treatments, particularly those with inherent DNA repair deficiencies.
• Exploiting the defective DDR in cancer cells offers a targeted approach to induce cancer cell lethality while sparing normal cells.
• Further research into DDR modulation holds promise for developing novel, effective cancer therapies.